Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals"Announcement on Obtaining Notice of Approval for Drug Clinical Trials

Sep 19, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Gan & Lee Pharmaceuticals Co., Ltd. Class A

"Gan & Lee Pharmaceuticals"Announcement on Completion of Industrial and Commercial Registration Information ChangeSep 9
"Gan & Lee Pharmaceuticals"Announcement on Completion of First Subject Dosing in the Phase I Clinical Trial of GZC8072 TabletsSep 8
"Gan & Lee Pharmaceuticals"Announcement on Obtaining Notice of Approval for Drug Clinical Trial for the New Indication of GZC8072 TabletSep 4
"Gan & Lee Pharmaceuticals."Announcement on Release of Pledge of Certain Shares Held by Shareholder Holding More Than 5% of the SharesAug 27

All Gan & Lee Pharmaceuticals Co., Ltd. Class A news releases